Role of Riociguat in Treatment of Exercise-Induced Pulmonary Hypertension

Journal of Cardiac Failure - United States
doi 10.1016/j.cardfail.2019.07.124
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

A Focus on Riociguat in the Treatment of Pulmonary Arterial Hypertension

Basic and Clinical Pharmacology and Toxicology
MedicineToxicologyPharmacology
2019English

Riociguat Is a Novel Medication for the Treatment of Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension

Medical Council
2016English

Early Observations on the Use of Riociguat in a Large, Metropolitan Pulmonary Arterial Hypertension/Chronic Thromboembolic Pulmonary Hypertension Treatment Center

Cardiology and Therapy
2015English

Exercise in Pulmonary Hypertension

Advances in Pulmonary Hypertension
2011English

The Soluble Guanylate Cyclase Stimulator Riociguat Ameliorates Pulmonary Hypertension Induced by Hypoxia and SU5416 in Rats

BMC Pharmacology
2011English

The Soluble Guanylate Cyclase Stimulator Riociguat Ameliorates Pulmonary Hypertension Induced by Hypoxia and SU5416 in Rats

PLoS ONE
Multidisciplinary
2012English

Treating Pulmonary Arterial Hypertension With Exercise: The Role of Rehabilitative Medicine

Advances in Pulmonary Hypertension
2019English

Acute Effects of Riociguat in Borderline or Manifest Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease

Pulmonary Circulation
PulmonaryRespiratory Medicine
2015English

Pulmonary Hypertension Roundtable: The Role of Exercise in Clinical Practice and Clinical Trials

Advances in Pulmonary Hypertension
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy